Aβ Dynamics in LLMD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Aβ Dynamics in LLMD — Stella

Home/Alzheimer Disease/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

United States

NYU Langone Health, New York, New York

Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York

Key details

Phase

Post-approval study

Sponsor

NYU Langone Health

Collaborators

National Institute on Aging (NIA)

Enrollment target

~60 participants

Started

February 2022

Primary completion

September 2026

Age range

60 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.